Nowack is responsible for all internal quality systems, oversight of external quality activities and DSCSA compliance for Edenbridge Pharmaceuticals. Jason Nowack, Vice President, Quality Assurance degree in Chemistry from Northern Illinois University. Das possesses over 20 years of experience in providing analytical support to development of IND, NDA, and ANDA drug products. Das held senior roles at Endo and Par Pharmaceuticals. Das is responsible for all product development & technical transfer activities at Edenbridge Pharmaceuticals. Worley holds a PharmD, magna cum laude, from Rutgers University and a JD, cum laude, from Seton Hall University.ĭr. Worley was an associate at Haug Partners LLP (f/k/a Frommer Lawrence & Haug LLP) where he specialized in patent and FDA regulatory law. Worley is a patent attorney and registered pharmacist who is responsible for all business development and legal operations at Edenbridge Pharmaceuticals. Worley Jr., PharmD, Esq., Senior Vice President, Business Development & General Counselĭr.

in Political Science from Purdue University.ĭaniel G. White held various sales & marketing roles at Nostrum Laboratories, Actavis, Rising Pharmaceuticals, and PACK Pharmaceuticals. White is responsible for the development and execution of Edenbridge Pharmaceuticals' generic sales & marketing strategy and leading all trade relations, product launches, sales infrastructure, customer service, and sales logistics related to Edenbridge's generic product portfolio. Mike White, Senior Vice President, Sales & Marketing degree in Accounting from Arizona State University and was formerly licensed as a CPA in California. Padre earned Summa Cum Laude honors while earning a B.S. Padre also served as an adjunct professor in accounting and information systems at The College of New Jersey. Padre served as the US Controller for Bausch Health Companies during a period of seventeen stock acquisitions and growth in market capital from $2B to $80B. Padre served as Vice President, Corporate Controller for Vertice Pharmaceuticals and prior to that Mr.

Padre has held finance positions in large multi-national publicly traded companies as well as small privately held pharmaceutical companies. Chu holds a law degree from Harvard Law School. Chu worked at Wyeth and was also previously an associate at the law firm of Skadden Arps. Chu was previously the Director of Business Development and Associate General Counsel for DAVA Pharmaceuticals. Chu is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as President.

Endo pharma vp compliance quality